KERYX BIOPHARMACEUTICALS INC

CUSIP: 492515101 Class: COMMON STOCK

IRIDIAN ASSET MANAGEMENT LLC/CT's Holding History (CIK: 0001033427)

Note: Option positions (PUT/CALL) are excluded.

Q2 2017
Shares 220,600 Value ($000) $1,595 Avg Close — Range —
Q1 2017
Shares 265,110 Value ($000) $1,633 Avg Close — Range —
Q4 2016
Shares 228,570 Value ($000) $1,339 Avg Close — Range —